We are conducting a two-year study on the safety, tolerability, and efficacy of a new monthly pill to prevent HIV. The study will compare this investigational medication to a currently approved option for PrEP.

Consider if you are:

• Not living with HIV

• 18+ years old

• A cisgender man, trans woman, trans man, or nonbinary person

• Someone who has had condomless receptive anal sex (bottomed) in the last 12 months with partners assigned male at birth.